scholarly journals Mapping of courses on vector biology and vector-borne diseases systems: time for a worldwide effort

2016 ◽  
Vol 111 (11) ◽  
pp. 717-719 ◽  
Author(s):  
Jérôme Casas ◽  
Claudio Lazzari ◽  
Teresita Insausti ◽  
Pascal Launois ◽  
Florence Fouque
Keyword(s):  
Vector Biology ◽  
Vector Borne Diseases ◽  
Vector Borne

The Biology of Disease Vectors, 2nd Edn (ed. Marquardt, W. C.), pp. 785. Elsevier Academic Press, USA, 2005. ISBN 0 12 473276 3. £62.99.

Parasitology ◽  
2006 ◽  
Vol 132 (1) ◽  
pp. 153-153
Author(s):  
HILARY HURD
Keyword(s):  
Disease Vectors ◽  
Academic Press ◽  
Disease Course ◽  
State University ◽  
Vector Biology ◽  
Colorado State University ◽  
Vector Borne Diseases ◽  
The Usa ◽  
History Of ◽  
Vector Borne

Vector biology has become a fast moving field. Spurred on by the recent exciting advances in the molecular biology, genomics and latterly proteomics of vector insects and their pathogens, researchers are using new approaches and our knowledge is rapidly increasing. The second edition of this volume very much reflects these advances. The editor, William Marquardt, has assembled a team of section editors to oversee the production of 57 short chapters, divided into 7 parts. With a few exceptions, these experts are drawn from the USA, a reflection no doubt of the history of the first edition which was produced to accompany the Biology of Vector Disease course, given at Colorado State University. The text is aimed at post-graduate and post-doctoral researchers, working in a range of areas associated with vector biology and vector-borne diseases. It provides an excellent opportunity to obtain an initial overview of a new area or to dip into a field that may be peripheral to the topic under investigation.

scholarly journals Predicting the effect of climate change on African trypanosomiasis: integrating epidemiology with parasite and vector biology

2011 ◽  
Vol 9 (70) ◽  
pp. 817-830 ◽  
Author(s):  
Sean Moore ◽  
Sourya Shrestha ◽  
Kyle W. Tomlinson ◽  
Holly Vuong
Keyword(s):  
Climate Change ◽  
Disease Transmission ◽  
Transmission Model ◽  
Future Research ◽  
African Trypanosomiasis ◽  
Vector Biology ◽  
Vector Ecology ◽  
Large Shift ◽  
Vector Borne Diseases ◽  
Vector Borne

Climate warming over the next century is expected to have a large impact on the interactions between pathogens and their animal and human hosts. Vector-borne diseases are particularly sensitive to warming because temperature changes can alter vector development rates, shift their geographical distribution and alter transmission dynamics. For this reason, African trypanosomiasis (sleeping sickness), a vector-borne disease of humans and animals, was recently identified as one of the 12 infectious diseases likely to spread owing to climate change. We combine a variety of direct effects of temperature on vector ecology, vector biology and vector–parasite interactions via a disease transmission model and extrapolate the potential compounding effects of projected warming on the epidemiology of African trypanosomiasis. The model predicts that epidemics can occur when mean temperatures are between 20.7°C and 26.1°C. Our model does not predict a large-range expansion, but rather a large shift of up to 60 per cent in the geographical extent of the range. The model also predicts that 46–77 million additional people may be at risk of exposure by 2090. Future research could expand our analysis to include other environmental factors that influence tsetse populations and disease transmission such as humidity, as well as changes to human, livestock and wildlife distributions. The modelling approach presented here provides a framework for using the climate-sensitive aspects of vector and pathogen biology to predict changes in disease prevalence and risk owing to climate change.

The Spread of Mosquito Borne Disease – Is Climate Change Beginning to Bite?

2019 ◽  
Vol 30 (5) ◽  
pp. 192-194
Author(s):  
John (Luke) Lucas
Keyword(s):  
Climate Change ◽  
Vector Borne Diseases ◽  
Vector Borne

The author considers the threat to vector-borne diseases in the light of climate change.

The Scientific Basis for the Prevention of Zooanthroponoze Vector-Borne Diseases Spread by Parasitic Arthropods of the Center of the East European Plain

2020 ◽  
Vol 14 (1) ◽  
pp. 81-88
Author(s):  
Fedor I. Vasilevich ◽  
Anna M. Nikanorova
Keyword(s):  
Mathematical Models ◽  
Culex Pipiens ◽  
Preventive Measures ◽  
Mosquito Species ◽  
Natural Habitat ◽  
Piperonyl Butoxide ◽  
East European Plain ◽  
Vector Borne Diseases ◽  
Vector Borne ◽  
Kaluga Region

The purpose of the research is development of preventive measures against zooanthroponoze vector-borne diseases spread by parasitic arthropods in the Kaluga Region. Materials and methods. The subject of the research was Ixodidae, mosquitoes, and small mammals inhabiting the Kaluga Region. The census of parasitic arthropods was carried out on the territory of all districts of the Kaluga Region and the city of Kaluga. Open natural habitat and human settlements were investigated. Weather conditions from 2013 to 2018 were also taken into account. For the purposes of the study, we used standard methods for capturing and counting arthropods and mouse-like rodents. In order to obtain mathematical models of small mammal populations, a full factorial experiment was conducted using the collected statistical data. In-process testing of the drug based on s-fenvalerate and piperonyl butoxide were carried out under the conditions of the agricultural collective farm “Niva” of the Kozelsky District, the Kaluga Region, and LLC “Angus Center of Genetics” of the Babyninsky District, the Kaluga Region. Results and discussion. In the Kaluga Region, two species of ixodic ticks are found, namely, Ixodes ricinus and Dermacentor reticulatus, which have two activity peaks. Mosquito may have 3-4 generations in a year in the Kaluga region. The most common mosquito species in the Kaluga Region are Aedes communis, Ae. (Och.) togoi and Ae. (Och.) diantaeus, Culex pipiens Culex Linnaeus, 1758 (Diptera, Culicidae) (Culex pipiens): Cx. pipiens f. pipiens L. (non-autogenic form) and Cx. p. f. molestus Fors. (autogenic form), which interbreed, and reproductively isolated in the Region. The developed mathematical models make it possible to quantify the risks of outbreaks of zooanthroponoze vector-borne diseases without the cost of field research, and allow for rational, timely and effective preventive measures. Medications based on s-fenvalerate and piperonyl butoxide and based on cyfluthrin showed high insecto-acaricidal efficacy and safety.

Current Challenges in the Development of Vaccines and Drugs Against Emerging Vector-borne Diseases

2019 ◽  
Vol 26 (16) ◽  
pp. 2974-2986 ◽  
Author(s):  
Kwang-sun Kim
Keyword(s):  
New Host ◽  
In Vivo Models ◽  
Vector Borne Diseases ◽  
Novel Drugs ◽  
Huge Impact ◽  
Tick Borne Disease ◽  
Vector Borne ◽  
Living Organisms

Vectors are living organisms that transmit infectious diseases from an infected animal to humans or another animal. Biological vectors such as mosquitoes, ticks, and sand flies carry pathogens that multiply within their bodies prior to delivery to a new host. The increased prevalence of Vector-Borne Diseases (VBDs) such as Aedes-borne dengue, Chikungunya (CHIKV), Zika (ZIKV), malaria, Tick-Borne Disease (TBD), and scrub typhus has a huge impact on the health of both humans and livestock worldwide. In particular, zoonotic diseases transmitted by mosquitoes and ticks place a considerable burden on public health. Vaccines, drugs, and vector control methods have been developed to prevent and treat VBDs and have prevented millions of deaths. However, development of such strategies is falling behind the rapid emergence of VBDs. Therefore, a comprehensive approach to fighting VBDs must be considered immediately. In this review, I focus on the challenges posed by emerging outbreaks of VBDs and discuss available drugs and vaccines designed to overcome this burden. Research into promising drugs needs to be upgraded and fast-tracked, and novel drugs or vaccines being tested in in vitro and in vivo models need to be moved into human clinical trials. Active preventive tactics, as well as new and upgraded diagnostics, surveillance, treatments, and vaccination strategies, need to be monitored constantly if we are to manage VBDs of medical importance.

scholarly journals Molecular survey of vector-borne diseases in two groups of domestic dogs from Lisbon, Portugal

2021 ◽  
Vol 14 (1) ◽  
Author(s):  
Ana Mafalda Dordio ◽  
Relja Beck ◽  
Telmo Nunes ◽  
Isabel Pereira da Fonseca ◽  
Jacinto Gomes
Keyword(s):  
Clinical Status ◽  
Molecular Methods ◽  
Hepatozoon Canis ◽  
Clinical Approach ◽  
Limited Information ◽  
Vector Borne Diseases ◽  
Wide Range ◽  
Other Information ◽  
Southern Portugal ◽  
Vector Borne

Abstract Background Canine vector-borne diseases (CVBDs) are caused by a wide range of pathogens transmitted by arthropods. They have been an issue of growing importance in recent years; however, there is limited information about the vector-borne pathogens circulating in Portugal. The aim of the present study was to detect canine vector-borne bacteria and protozoa of veterinary and zoonotic importance using molecular methods. Methods One hundred and forty-two dogs from Lisbon, southern Portugal, were tested: 48 dogs from a veterinary hospital clinically suspected of vector-borne diseases and 94 apparently healthy dogs from shelters. Anaplasma spp./Ehrlichia spp., Babesia/Theileria spp., Hepatozoon spp., and Mycoplasma spp. infections were detected by PCR from blood samples and examined under light microscopy. Other information including clinical status and diagnostic test results were collected for each animal. Results Infections were detected by PCR in 48 (33.80%) dogs. Single infections were found in 35 dogs (24.64%), and co-infections were found in 13 (9.15%) dogs. Twenty-nine (20.42%) dogs were positive for Hepatozoon spp., 15 (10.56%) for Mycoplasma spp., 11 (7.75%) for Anaplasma spp./Ehrlichia spp., and six (4.21%) for Babesia spp. DNA sequencing was used to identify Babesia vogeli (2.81%), Babesia canis (1.40%), Hepatozoon canis (20.42%), Mycoplasma haematoparvum (2.11%), Mycoplasma haemocanis (8.45%), Anaplasma platys (7.04%), and Ehrlichia canis (0.70%). Conclusions This is the first molecular identification of B. canis and M. haematoparvum in dogs from southern Portugal. This study highlights the importance of molecular methods to identify CVBD pathogens in endemic areas and helps to guide the clinical approach of veterinarians in practice.

Sign in / Sign up

Export Citation Format

Share Document